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ABSTRACT	
  
This study examined how the mode of onset for myalgic encephalomyelitis and
chronic fatigue syndrome (ME and CFS) impacts patients’ presenting symptomatology. Specifically,
this study investigated the differences between the most commonly reported ME and CFS onsets:
infectious, stress-related, and a combined infectious and stress-related onset (referred to as ‘combined
onset’). Three patient samples were combined and utilized. All participants met Fukuda et al. (1994)
criteria and self-reported their illness onset. Analyses showed the infectious group reported the most
impairment for general health functioning—which relates to the susceptibility of getting or feeling
sick—in comparison to the stress-related group. Meanwhile, both the stress-related and combined
groups reported more impairment for mental health functioning than the infectious group. Lastly, the
infectious and combined groups reported worse autonomic and immune symptomatology than the
stress group. These findings illustrate that the mode of onset for ME and CFS could play a factor in a
patient’s prognosis. An infectious onset might lead to worse physical and somatic symptoms, while a
stress onset might lead to worse psychological functioning. These findings are consistent with prior
research. Future research should continue investigating the differences among patients based on illness
onset, as well as other factors (e.g., psychiatric co-morbidity).	
  

	
  

	
  
	
  
INTRODUCTION	
  

Myalgic encephalomyelitis and chronic fatigue
syndrome (ME and CFS) are elusive illnesses
with controversial etiologies (Afari &
Buchwald, 2014). While numerous case
definitions exist (Carruthers et al., 2003;
Carruthers et al., 2011; Fukuda et al., 1994), ME
and CFS are characterized by a variety of core

symptoms including profound fatigue, postexertional malaise, impairment of memory and
concentration, unrefreshing sleep, arthralgia
and/or myalgia, and several autonomic,
neuroendocrine, and immune manifestations
(Carruthers et al., 2003). Patients often report an
infectious onset, stress-related onset, or a
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combined infectious and stress-related onset
(Becker, McGregor, & Meirleirxy, 2002).
Within these different patient groups, various
ME and CFS sub-types might exist (Jason et al.,
2001). Therefore, research should examine how
the symptomatology of these sub-types differs,
as treatments could be tailored to patients
accordingly. This study investigates how the
mode of illness onset for ME and CFS affects
the
presenting
symptomatology
and
functionality of patients.	
  
An infectious onset of ME and CFS is defined
by a patient having a transferrable illness (e.g.
Epstein-Barr virus) prior to contracting ME or
CFS. Infectious onsets have been referred to as
sudden events, and people with this type of onset
are more likely to attribute their illness to a
physical cause (Butler, Chalder, & Wessely,
2001; Komaroff, 1988). One study found a
greater likelihood for this group to be socially
extraverted before their illness (Masuda,
Munemoto, Yamanaka, Takei, & Tei, 2002).
Research has shown physical attributions to be
more often reported than psychological
attributions (Butler et al., 2001; White, Lehman,
Hemphill, Mandel, & Lehman, 2006). An
infectious onset may also lead to worse
functional impairment (Sharpe, Hawton,
Seagroatt, & Pasvol, 1992), worse memory
problems, (DeLuca, Johnson, Ellis, & Natelson,
1997), and a decreased likelihood of
improvement over time (Vercoulen et al., 1996).
Over the years, three families of viruses—herpes
viruses, enteroviruses, and retroviruses—have
been studied, but identifying a single infectious,
etiological agent for ME and CFS has been
inconclusive (Lorusso et al., 2009). Investigators
have posited that some pathophysiological
anomalies may precipitate or perpetuate ME and
CFS, but the illness is likely multi-faceted. An
aggregate of immunological studies suggests a
“hit and run” effect, where a patient contracts a
virus that causes immune abnormalities, which
then leads to ME and CFS; however, when the
virus is eliminated, the patient’s immune system
remains in an activated state (Lorusso et al.,
2009).While no single etiological agent has been
determined, many patients attribute their illness
solely to an infection, and thus, research should

https://via.library.depaul.edu/depaul-disc/vol5/iss1/6

continue comparing their prognosis to those of
patients with other onset modes.
Many patients report the development of their
ME and CFS to occur after stressful life events
(e.g., vehicle accident, surgery) (Becker et al.,
2002; Hatcher & House, 2003; Theorell,
Blomkvist, Lindh, & Evengard, 1999; Wessely
et al., 1995). Although the majority of patients
report an infection to play some role in their
onset (Anderson, Jason, & Hlavaty, 2014; Butler
et al., 2001), some patients have no clinical or
laboratory evidence of viral infection (Farrar,
Locke, & Kantrowitz, 1995). Hatcher and House
(2003) found stressful life events—which
occurred three months prior to ME and CFS—to
be common. Noting these events is important, as
psychological strain has been theorized to impair
the Hypothalamic-Pituitary Adrenal axis (HPAaxis),
which
would
disturb
the
neuroendocrinological responses in ME and CFS
patients (Cleare, 2003). When the HPA-axis
becomes dysregulated and over-produces
cortisol and dehydroepiandrosterone, a person’s
immune system may weaken (Cohen, JanickiDeverts, & Miller, 2007; Morale et al., 2001);
thus, stress could prompt the development of
ME and CFS.
A stress-related onset has often been reported as
a gradually occurring process (DeLuca et al.,
1997). Because this group is more likely to
endure difficult life events, they may be more
inclined to believe they played a role in causing
their illness (internal attribution), which may
lead to depressive symptoms (Peterson,
Schwartz, & Seligman, 1981). For example, if
someone ascribed their illness to work stress,
they might take blame for their illness because
they felt they could have reduced their work
hours. However, once sick with ME and CFS,
they no longer believe they have control over
their symptoms (White et al., 2006). Research
has suggested that people with an internal
(psychological) attribution, who also have an
external locus of control over their ME or CFS,
will have worse psychological adjustment
(White et al., 2006).
Congruent with the convoluted nature of ME
and CFS, many patients attribute their illness to
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a combination of infection and stress-related
factors (Becker et al., 2002; Butler et al., 2001;
Theorell et al., 1999). These multi-faceted onset
attributions support theories that ME and CFS
are heterogeneous in nature (Afari & Buchwald,
2014).
The goal of this study was to examine how the
mode of ME and CFS onset impacts patients’
presenting symptomatology. While other ME
and CFS onset modes exist, this study
investigated the differences between the most
commonly reported onsets: infectious, stressrelated, and a combined infectious and stressrelated onset (referred to as ‘combined onset’).
Based on previous research, and the physical
nature of an infection, we predicted that an
infectious onset would result in more severe
symptomatology
and
impaired
physical
functioning when compared to a stress-related
onset. Conversely, we predicted that a stressrelated onset would result in worse mental
functioning when compared to an infectious
onset. Lastly, we predicted that a combined
onset would result in worse physical and mental
functioning, as well as worse symptomatology,
compared to the other two groups, as the twofold effect of both an infection and stress may
compound impairment.
METHODS	
  
PARTICIPANTS	
  
Three patient samples were combined and
utilized: the DePaul sample, the Norway sample,
and the Newcastle-uponTyne Royal Victoria
Infirmary sample. Case ascertainment methods
differed between the samples. Participants in the
DePaul sample were adults who self-identified
as having CFS, ME/CFS, or ME; participants in
the Norway sample were diagnosed with CFS by
a physician or medical specialist, or came from
an inpatient medical ward for severely ill
patients, or were from an outpatient clinic; and
participants in the Newcastle-uponTyne Royal
Victoria Infirmary sample were recruited from a
primary care setting, after completing a medical
workup. All participants had to meet the Fukuda
et al. (1994) criteria to be included in the present
study.

Published by Digital Commons@DePaul, 2016

DePaul	
  Sample	
  
Eligibility for inclusion was met with the
following criteria: an individual needed to be (a)
between the ages of 18 and 65; (b) literate in
English; (c) and have a self-reported current
diagnosis of CFS, ME/CFS, or ME. Recruitment
occurred in a variety of settings, including posts
on internet forums, contacting support groups,
and following up with individuals who
previously participated in a DePaul study while
expressing interest in future studies. In addition,
individuals who had emailed the team with
interest in future studies were contacted. Three
options were available for survey completion: an
electronic survey, a hard-copy survey, or a
verbal survey over the telephone. Surveys could
be completed either at home or in-person at
DePaul University’s Center for Community
Research. Five-dollar Amazon.com gift cards
were given to the first 100 individuals who
completed the survey.
Norway	
  Sample	
  
This sample consisted of patients from four midsized towns in southern Norway, as well as an
inpatient medical ward and an outpatient clinic
at a multidisciplinary CFS/ME center.
Recruitment occurred through healthcare
professionals, a waiting list for a patient
education
program,
and
CFS
patient
organizations. Participants needed to be between
18 and 65 years old and be literate in
Norwegian. Before participants could be
included in the sample, they had to complete a
written informed consent process.
Newcastle	
  Sample	
  
This sample consisted of participants who were
suspected of having CFS by primary care
physicians after a complete medical assessment
at the Newcastle-upon-Tyne Royal Victoria
clinic. At the clinic, an experienced consultant
physician collected a comprehensive medical
history and examined each individual. Those
who met eligibility criteria completed a written
informed consent process before being included
in the sample. They completed the study
measures by hard copy.

3
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MEASURES	
  
Medical	
   Outcomes	
   Study	
   36-‐item	
   Short-‐Form	
  
Health	
  Survey	
  (SF-‐36	
  or	
  RAND-‐36)	
  
All participants completed the SF-36. This 36item measure allows participants to self-report
their functional and mental health status. Scores
on 100-point scales are calculated for the
following domains: physical functioning, role
physical (a measure of the impact of physical
health problems on ability to fulfill life roles),
bodily pain, general health (a measure of global
perceptions
of
overall
health),
social
functioning, mental health functioning, role
emotional (a measure of the impact of mental
health problems on ability to fulfill life roles),
and vitality (a measure of fatigue/energy).
Higher scores indicate better health or less
impact of health on functioning. On this form,
an example question reads: How true or false is
each of the following statements for you? I
expect my health to get worse (Definitely true;
Mostly true; Don’t know; Mostly false;
Definitely false). Studies assessing the SF-36
construction have found adequate internal
consistency, significant discriminant validity
among subscales, and substantial differences in
the pattern of scores between patient and nonpatient populations (McHorney, War Jr, Lu, &
Sherbourne, 1994).
	
  
The	
  DePaul	
  Symptom	
  Questionnaire	
  (DSQ)	
  
All participants also completed the DSQ (Jason
et al., 2010). This measure allows participants to
self-report their illness onset, symptomatology,
demographics, and medical, occupational, and
social history. On a five-point Likert-scale,
participants rated the frequency and severity of
54 symptoms over the past six months. For
frequency, the items state “Throughout the past
6 months, how often have you had this
symptom?” (0 = none of the time, 1 = a little of
the time, 2 = about half the time, 3 = most of the
time, and 4 = all of the time). For severity, the
items state “Throughout the past 6 months, how
much has this symptom bothered you?” (0 =
symptom not present, 1 = mild, 2 = moderate, 3=
severe, and 4 = very severe). Frequency and
severity scores were each multiplied by 25 to

create 100-point scales. The 100-point frequency
and severity scores for each symptom were then
averaged to create one score per symptom. The
development of the DSQ was based upon the
Clinical Canadian Criteria (Carruthers et al.,
2003), which identifies seven symptom domains
(fatigue/post-exertional malaise, neurological
dysfunction, sleep dysfunction, pain, autonomic
dysfunction,
immune
dysfunction,
and
neuroendocrine dysfunction). Thus, DSQ
symptom scores are grouped by these seven
theoretical domains for analysis. Among both
patient and control groups, the DSQ has
illustrated good test-retest reliability (Jason, So,
Brown, Sunnquist, & Evans, 2015) with factors
evidencing good internal consistency (Brown &
Jason, 2014).
	
  
ANALYSIS	
  
	
  
Participants were divided into one of three onset
groups—infectious,
stress,
or
combined
infectious and stress—based on their responses
to the DSQ item: Did your fatigue/energy
related illness start after you experienced any of
the following? (Check one or more and please
specify): An infectious illness, An accident, A
trip or vacation, An immunization (a shot at
doctor’s office), Surgery, Severe stress (bad or
unhappy events), Other (please list), I am not ill.
Although participants could have marked more
than one answer to the DSQ onset item, they
were only included in this study if they reported
an infectious, stress, or combined infectious and
stress onset. For instance, if a participant
reported an infectious onset and an onset after a
trip or vacation, they would be assigned to the
infectious-only group. Similarly, if a participant
reported a stress onset and an onset after a trip or
vacation, they would be assigned to the stressonly group. The infectious, stress, and combined
infectious and stress onset groups are the most
likely precipitating factors of ME and CFS
(Becker et al., 2002), while events like an
accident, trip or vacation, an immunization, or
surgery might precipitate an infection or cause
stress (e.g., someone contracts an infection while
on a trip). If, however, a participant reported
having an infectious and stress onset, they were
assigned to the combined group. A multivariate
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analysis of variance (MANOVA) was used to
compare these three groups on symptomatology
and the SF-36 subscales, followed up by
univariate and post-hoc comparisons when
indicated. An alpha level of .05 was used for all
statistical tests.	
  
	
  
RESULTS	
  
SAMPLES	
  
The combined sample (DePaul, Newcastle, and
Norway) consisted of 495 participants.
However, 101 of these participants were
excluded because they did not endorse either an
infectious or stress onset; four of these excluded
participants endorsed “onset after an accident,”
four endorsed “after a trip or vacation,” 11
endorsed “after an immunization,” 17 endorsed
“after surgery,” and 56 selected “other.” After
these exclusions, the combined sample was 394
participants; 151 were included from the DePaul
sample, 60 were included from the Newcastle
sample, and 183 were included from the Norway
sample. These three groups were not
significantly different on mode of illness onset,
ethnicity or gender. However, there were
significant differences between the samples on
age [F(2, 372) = 22.67, p<.001], education level
[X2(15, 389) = 178.50, p<.001], and work status
[X2(12, 373) =167.14, p<.05].
The DePaul sample was significantly older than
the other two samples with a mean age of 51.8,
compared to the Newcastle sample with a mean
of 45.9, and the Norway sample with a mean of
42.4. Regarding educational level achieved, the
DePaul sample was the most educated, followed
by the Newcastle sample, and then the Norway
sample (80%, 53.45%, and 49.17% completed at
least a standard college degree). Regarding work
status, a greater percentage of the DePaul
sample was unemployed compared to the
Norway sample, and a greater percentage of the
Norway sample was on disability compared to
the DePaul sample.
	
  
Table 1 provides demographic information for
the three onset groups: 213 individuals were
categorized as “infectious onset,” 59 individuals
were categorized as “stress onset,” and 122

Published by Digital Commons@DePaul, 2016

individuals were categorized as “combined
infectious and stress onset.” Statistical analyses
showed only one significant difference between
the groups. A chi-squared test found participants
with a stress-related onset were more likely to
report having children compared to the
infectious and combined groups, X2(2,
391)=9.818, p=.007. The vast majority of
participants in each group were female, white,
and on disability.
	
  
FUNCTIONAL	
  STATUS	
  
Table 2 displays the SF-36 data. A multivariate
analysis of variance (MANOVA) found that the
three groups differed overall on these subscales
[Wilks’ Lamda = .894, F(16, 728)=2.632,
p<.001]. The univariate tests revealed a
significant overall difference on general health
functioning [F(2, 374)=3.982, p=.019], mental
health functioning [F(2, 374)=8.55, p<.001], and
role emotional functioning [F(2, 374)=6.247,
p=.002]. There was a minor violation for
homogeneity of between-group variance on the
Role Emotional scale, but Brown-Forsythe F
and Welch’s F adjustments showed that this had
no impact on the observed outcome. The other
subscales were non-significant. Bonferroni posthocs revealed that the infectious group had
significantly worse general health than the stress
group (p=.019). The combined group neared
significance (p=.061), reporting worse general
health functioning than the stress-related group.
The infectious group had significantly better
mental health functioning than both the stressrelated (p=.004) and combined groups (p=.002).
Additionally, a Games-Howell post-hoc test was
conducted on the Role Emotional subscale, as
this category did not meet the homogeneity of
variance assumption. This test found that the
combined group reported the worst functioning
on the role emotional scale, but was only
significantly worse than the infectious group (p
= .004).
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Table 1. Demographics (N= 394)

Age
Sex
Male
Female
Race
White
Asian/Pacific Islander
Other
Education
Less than high school
Some high school
HS degree or GED
Partial college
Standard college degree
Graduate degree
Marital Status
Married/partnered
Separated
Widowed
Divorced
Never Married
Children
Yes
No
Work Status
On disability
Student
Homemaker
Retired
Unemployed
Working part-time
Working full-time

Infectious
(n=213)
M (SD)

Stress
(n=59)
M (SD)

Combined
(n=122)
M (SD)

46.88 (14.20)

47.53 (10.79)

46.19 (11.92)

% (n)

% (n)

% (n)

16.4 (35)
83.6 (178)

12.1 (7)
87.9 (51)

17.2 (21)
82.8 (101)

97.6 (206)
0.5 (1)
1.9 (4)

98.3 (58)
1.7 (1)
0

99.2 (121)
0
.8 (1)

5.7 (12)
2.4 (5)
21.3 (45)
9.0 (19)
35.5 (75)
26.1 (55)

5.2 (3)
0 (0)
24.1 (14)
13.8 (8)
39.7 (23)
17.2 (10)

3.3 (4)
0.8 (1)
25.8 (31)
5.8 (7)
36.7 (44)
27.5 (33)

55.5 (116)
.5 (1)
1 (2)
12.4 (26)
30.6 (64)

55.9 (33)
1.7 (1)
0 (0)
18.6 (11)
23.7 (14)

51.3 (61)
1.7 (2)
1.7 (2)
13.4 (16)
31.9 (38)

46.4 (98)
53.6 (113)

69.5 (41)
30.5 (18)

52.1 (63)
47.9 (58)

59.7 (120)
5.0 (10)
2.0 (4)
10.4 (21)
7.5 (15)
9 (19)
6 (12)

67.3 (37)
0 (0)
1.8 (1)
7.3 (4)
0 (0)
16.4 (9)
7.3 (4)

64.1 (75)
2.6 (3)
4.3 (5)
6 (7)
7.7 (9)
13.7 (16)
1.7 (2)

p
.801
.661

.426

.758

.007
.134

In summary, the infectious group showed the
worst general health functioning, but the highest
mental health functioning compared to the other
groups. On the contrary, the stress-related and
combined group reported the worst mental
health functioning. Additionally, the combined

https://via.library.depaul.edu/depaul-disc/vol5/iss1/6

group showed comparable general health
functioning to the infectious group; however,
this finding should be taken with caution as it
was not statistically significant. Lastly, the
combined group reported the worst role
emotional scores.
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Table 2. Differences in functioning (SF-36 subscales) across modes of illness onset (N = 374)
Infectious
Stress
Combined
p
(n=201)
(n=57)
(n=116)
M (SD)
M (SD)
M (SD)
Physical Functioning
36.25 (23.49)
42.10 (19.45)
37.05 (22.67)
.223
Role Physical
7.42 (20.03)
5.70 (18.30)
4.53 (12.60)
.366
Bodily Pain
40.12 (22.83)
34.71 (21.63)
40.21 (23.48)
.256
General Health
26.87 (15.61)a
33.61 (17.42)a
27.54 (16.36)
.019
Social Functioning
25.50 (23.01)
27.85 (21.39)
22.61 (22.45)
.764
ab
a
b
Mental Health
74.02 (16.45)
65.84 (18.14)
67.36 (16.87)
<.001
Role Emotional
82.59 (34.81)a
71.93 (41.21)
67.24 (43.07)a
.002
Vitality
18.18 (15.86)
19.36 (15.61)
16.89 (15.21)
.578
ab
Similar letters note significant differences

	
  

SYMPTOMATOLOGY	
  	
  
Based on the symptom categories of the Clinical
Canadian Criteria (Carruthers et al., 2003), the
symptoms were categorized into the following
domains for analysis: Fatigue/Post-Exertional
Malaise (six symptoms), Sleep (six symptoms),
Pain (seven symptoms), Neurological (13
symptoms), Autonomic (seven symptoms),
Neuroendocrine (ten symptoms), and Immune
(five symptoms). MANOVA was used to
compare the three groups on the unique
collection of symptoms from each of the seven
theoretical symptom domains of the DSQ. The
three groups were significantly different on the
Autonomic
[Wilks'
Lambda=.93,
F(2,
367)=1.904, p=.023] and Immune domains
[Wilks' Lamda= .947, F(2, 359)=1.943, p=.037].
However, the Fatigue/Post- Exertional Malaise,
Sleep, Pain, Neurological, and Neuroendocrine
domains were non-significant.

Table 3 displays the Autonomic symptoms. The
univariate tests revealed a significant difference
between the groups for nausea [F(2, 370)=4.093,
p=.017] and irregular heartbeats [F(2,
370)=4.949, p=.008]. Bonferroni post-hoc tests
found the infectious and combined groups
experienced worse nausea and irregular
heartbeats than the stress group. The items
dizziness or fainting [F(2, 370)=2.976, p=.052]
and unsteady on one’s feet [F(2, 370)=2.595,
p=.076] approached significance.
Table 4 presents the Immune items. Univariate
tests revealed a significant difference between
the groups for sensitivity to smells/foods, etc.
[F(2, 359)=3.482, p=.032] and flu-like
symptoms
[F(2,
359)=4.452,
p=.012].
Bonferroni post-hoc tests found the combined
group to experience

Table 3. Differences in autonomic symptoms across modes of illness onset (N=370)
Infectious
(n=198)
M (SD)
Bladder problems
27.90 (30.24)
Irritable bowel problems
47.16 (31.72)
Nausea
36.93 (26.81)a
Unsteady on your feet
43.24 (28.40)
Shortness of breath
41.22 (28.10)
Dizziness or fainting
42.42 (27.73)
Irregular heartbeats
33.84 (28.21)a
ab
Similar letters note significant differences

Stress
(n=53)
M (SD)
33.73 (38.10)
46.70 (33.72)
25.71 (23.18)ab
33.73 (25.31)
34.67 (31.26)
32.78 (24.42)
23.35 (23.52)ab

Combined
(n=119)
M (SD)
29.90 (32.72)
52.84 (34.84)
37.50 (28.79)b
39.81 (27.18)
40.91 (28.34)
42.33 (25.37)
37.92 (29.65)b

p

.418
.291
.017
.076
.317
.052
.008
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Table 4. Differences in immune symptoms across modes of illness onset (N=359)
Infectious
(n=194)
M (SD)
Sore throat
39.82 (27.55)
Lymph nodes
40.08 (30.35)
Fever
20.72 (24.50)
Flu-like symptoms
56.96 (25.76)a
Sensitivity to smells/foods/ 44.39 (36.10)
medications/ chemicals
ab
Similar letters note significant differences
significantly
worse
sensitivity
problems
compared to the stress group, but not the
infectious group. Both the infectious and
	
  
DISCUSSION	
  
	
  
This study adds to the literature of predicting the
prognosis of ME and CFS based upon
knowledge of illness onset. Previous work has
shown that illness attribution (physical vs.
psychological),
illness
duration,
an
internalization of symptoms, a psychiatric comorbidity, and stressful life events play a role in
a patient’s outcome. Given these findings, we
hypothesized that an infectious onset would lead
to different levels of symptom impairment
compared to a stress-related onset. Specifically,
we predicted that an infectious onset would lead
to
worse
physical
well-being
and
symptomatology, while a stress-related onset
would lead to worse mental well-being. Further,
we predicted that a combined infectious and
stress-related
onset
would
compound
symptomatology, perhaps limiting one’s ability
to cope, resulting in the worst impairment for
both physical and mental well-being, and more
severe symptomatology.
The findings lend some support to these
hypotheses. Analyses showed the infectious
group reported the most impairment for general
health functioning—which relates to the
susceptibility of getting or feeling sick (e.g. “I
seem to get sick more than most people”)—in
comparison to the stress-related group. This data

Stress
(n=51)
M (SD)
35.04 (23.32)
32.84 (28.61)
20.10 (23.19)
47.06 (26.53)ab
35.05 (35.88)a

Combined
(n=114)
M (SD)
41.78 (27.47)
35.42 (27.47)
19.96 (23.74)
60.09 (26.39)b
50.82 (35.60)a

p

.335
.198
.961
.012
.032

combined group reported significantly worse
flu-like symptoms compared to the stress group.
is congruous with the notion that people with an
infectious onset could still be suffering from the
ramifications of a virus or bacterium (Lorusso et
al., 2009). Although not statistically significant
from the other two groups, the combined group
also reported impairment for general health
functioning
The data also support our hypothesis that a
stress-related and combined onset would result
in worse mental well-being compared to an
infectious onset. For the mental health subscale,
both the stress-related and combined groups
reported more impairment than the infectious
group. This data corroborates prior research that
stressful life events and the internalization of
symptoms may hamper one’s ability to
psychologically cope. However, only the
combined group experienced more impairment
on the role emotional subscale compared to the
infectious group; this finding also supports our
hypothesis that the combined group would
report the worst overall impairment in mental
well-being. These findings suggest that the twofold factor of contracting an infection—and
experiencing life stress—could increase the risk
for emotional impairment over time
Furthermore, we found differences between
these onset groups within the autonomic and
immune symptom domains. As predicted, the
infectious and combined groups reported worse
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autonomic and immune symptomatology than
the stress group. Nausea, irregular heartbeats,
and flu-like symptoms were found to be
significantly worse in the infectious and
combined groups; the combined group also had
worse
sensitivity
to
smells/foods/medications/chemicals than the
stress group. Although non-significant, the
infectious and combined groups reported worse
impairment for the dizziness or fainting
symptom. Because this symptom relates to
general health functioning (e.g. feeling sick),
and may co-occur with an infection, researchers
and physicians should be cognizant that this
symptom could be worse—or more prevalent—
in patients with an infectious onset. Taken as a
whole, these results support the speculation that
patients with an infectious onset could be
affected by an overactive immune system
(Lorusso et al., 2009).
These findings illustrate that the mode of onset
for ME and CFS could play a factor in a
patient’s prognosis. An infectious onset might
lead to worse physical and somatic symptoms,
while a stress onset might lead to worse
psychological functioning. Therefore, both
physicians and researchers should make note of
illness onset when working with patients. The
field’s focus on psychological factors has
frustrated many patients with ME and CFS.
Patients with ME and CFS have commonly
expressed dissatisfaction with their physicians
regarding stigma and inadequate treatment
(Åsbring & Närvänen, 2002; Dickson, Knussen,
& Flowers, 2007). In the past, patients have
reproached physicians for not believing ME and
CFS to be an organic illness (Deale & Wessely,
2001). Therefore, tailoring treatments for this
diverse patient population is of great importance.
The present study’s limitations must also be
noted. We did not apply psychiatric exclusions
when determining which participants to include
in the present study. A comorbid psychiatric
illness might impact a participant’s functioning
and illness experience, and we were unable to
account for this when comparing onset groups.
A second limitation is the method of classifying
patients into the three onset groups. Although
patients could have reported multiple types of

Published by Digital Commons@DePaul, 2016

onset, we categorized only into an infectious
onset, stress-related onset, and a combined
onset. For instance, a participant who listed both
infectious onset and got their illness after
vacation would be sorted into the infectious
group. This decision was made based on the
previous research, as these three onsets appear to
be the most commonly endorsed triggers for the
illness (Afari & Buchwald, 2014; Becker et al.,
2002; White et al., 2006). Furthermore, the other
onsets (e.g. an accident, trip or vacation,
immunization, surgery) may commonly co-occur
with an infectious or stress onset. For instance, a
patient might have had surgery, experienced
stress because of the surgery, and then
contracted ME and CFS.
Additionally, the present study included
participants from three unique samples that were
recruited differently and had both demographic
similarities and differences. The resulting
combined sample was thus not homogeneous,
and it may be more appropriate to study
subsamples of patients stratified by case
ascertainment method in the future. We selected
to combine these groups to allow for greater
statistical power in our subsequent analyses.
Notably, when participants were categorized
into the three onset groups, the resulting groups
were comparable on almost all demographic
outcomes. Additionally, our distribution of the
three illness onset groups is consistent with other
research samples (Becker et al., 2002; Salit,
1997; White et al., 2006). About 68% of our
sample believed an infection played some role in
their onset, and 37% believed stress played some
role. White and colleagues (2006) found 61% of
their sample attributed their illness to either a
flu, virus, bacteria, or infection, and 43%
attributed their illness to either stress, overwork,
or over activity. Becker and colleagues (2002)
also identified infections to be combined with
non-infectious stressors, such as psychological
stress, in the onset of ME and CFS. Finally, this
study relied on self-report data, and thus, there
was no outside, objective documentation of the
participants’ illness onset.
Over the years, findings regarding the onset of
ME and CFS and subsequent functioning and
symptomatology have been equivocal, and the

9

DePaul Discoveries, Vol. 5 [2016], Iss. 1, Art. 6

	
  
illness experiences amongst patients have been
variable. However, by investigating ME and
CFS onset, we may gain a better understanding
of a patient’s illness progression, which may
inform the development and implementation of
	
  

treatments. The findings of this study
corroborate prior research. Future research
should continue investigating the differences
among patients based on illness onset, as well as
other factors (e.g., psychiatric co-morbidity).
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